| Hanover Hill Health Care Center | |
| 700 Hanover Street, Manchester, New Hampshire 03104 | |
| (603) 627-3826 | |
| Name | Hanover Hill Health Care Center |
|---|---|
| Location | 700 Hanover Street, Manchester, New Hampshire |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 124 |
| Occupancy Rate | 84.44% |
| Medicare ID (CCN) | 305009 |
| Legal Business Name | Hanover Hill Health Care Center Services Inc. |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
One of the challenges facing the food industry is how to create tasty, convenient and experiential products made from health promoting ingredients.
An Iowa hospital has agreed to pay $4.5 million to the federal government to settle claims that it illegally overpaid physicians in an effort to boost business.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
In multiple sclerosis, gray matter atrophy is extensive, and cognitive deficits and mood disorders are frequently encountered. It has been conjectured that focal atrophy is associated with emotional decline.
The Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region recently received $23.7 in funding from the USDA National Institute for Food and Agriculture.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.84 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.67 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.38 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.89 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 7.62 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 18.58 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.43 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.71 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.88 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.89 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.45 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 23.17 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.91 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.52 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.82 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.09 | 82.93 |
News Archive
One of the challenges facing the food industry is how to create tasty, convenient and experiential products made from health promoting ingredients.
An Iowa hospital has agreed to pay $4.5 million to the federal government to settle claims that it illegally overpaid physicians in an effort to boost business.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
In multiple sclerosis, gray matter atrophy is extensive, and cognitive deficits and mood disorders are frequently encountered. It has been conjectured that focal atrophy is associated with emotional decline.
The Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region recently received $23.7 in funding from the USDA National Institute for Food and Agriculture.
› Verified 9 days ago
Hanover Hill Health Care Center Location: 700 Hanover Street, Manchester, New Hampshire 03104 Phone: (603) 627-3826 | |
Maple Leaf Health Care Center Location: 198 Pearl Street, Manchester, New Hampshire 03104 Phone: (603) 669-1660 | |
Hackett Hill Healthcare Center Location: 191 Hackett Hill Road, Manchester, New Hampshire 03102 Phone: (603) 668-8161 | |
Courville At Manchester Location: 44 West Webster Street, Manchester, New Hampshire 03104 Phone: (603) 647-5900 | |
Mount Carmel Rehabilitation And Nursing Center Location: 235 Myrtle Street, Manchester, New Hampshire 03104 Phone: (603) 627-3811 | |
Saint Teresa Rehabilitation & Nursing Center Location: 519 Bridge Street, Manchester, New Hampshire 03104 Phone: (603) 668-2373 |